HIV dementia and the basal ganglia

Intervirology
Joseph R Berger, A Nath

Abstract

Infection with the human immunodeficiency virus frequently results in a dementing illness which manifests predominantly as a subcortical dementia. Parkinsonian features may be prominent in these patients and may on occasion be the presenting manifestation. These patients are exquisitely sensitive to dopaminergic blocking agents. Radiological studies, metabolic uptake studies and pathological examination of the brain suggest that the basal ganglia are the major target of this infection. Although further studies are necessary to determine appropriate treatment for this condition and to develop an understanding of the underlying pathophysiological mechanisms, available evidence suggests that the response to dopamine agonists may be variable and that viral strains and viral products may specifically target cells within the basal ganglia.

Citations

Jul 2, 2003·Neurotoxicity Research·P Riederer
Nov 2, 2005·Neurotoxicity Research·K F HauserP E Knapp
Feb 12, 2008·AIDS and Behavior·Andrew J LevinePaul Shapshak
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Benjamin B GelmanVicki M Soukup
Jan 26, 2011·Brain Imaging and Behavior·James T BeckerUNKNOWN Multicenter AIDS Cohort Study
Aug 17, 2002·Trends in Neurosciences·Malcolm J AvisonJoseph R Berger
Nov 16, 2011·Journal of Clinical and Experimental Neuropsychology·Andrew J LevineElyse J Singer
Jun 5, 2002·AIDS·Glenn J Treisman, Adam I Kaplin
Apr 13, 2004·AIDS·Christian R DolderDilip V Jeste
Apr 7, 2011·Current Opinion in Neurology·Patrick GannonDennis L Kolson
Jan 15, 2013·American Journal of Alzheimer's Disease and Other Dementias·J M FoleyC H Hinkin
Jul 9, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Italo MocchettiValeriya Avdoshina
Jun 4, 2008·Psychosomatic Medicine·Martin J Repetto, John M Petitto
May 2, 2014·Nuclear Medicine Communications·Mike SathekgeEkaterina Dadachova
Apr 17, 2014·Journal of Neurovirology·Andrew J LevineUNKNOWN Neuropsychology Working Group of the Multicenter AIDS Cohort Study
Oct 19, 2006·Journal of Biomedicine & Biotechnology·David R Wallace
Apr 26, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Landhing M MoranCharles F Mactutus
Jan 24, 2015·Molecular and Cellular Neurosciences·Ruturaj R MasvekarPamela E Knapp
Nov 17, 2009·Journal of Neuroimmunology·Jinsong PengSulie L Chang
Jun 26, 2004·The European Journal of Neuroscience·Valeriya K KhurdayanKurt F Hauser
Dec 16, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Stewart A FactorSusan A Weaver
Dec 8, 2004·Journal of Neuroimmunology·Malcolm J AvisonJoseph R Berger
Jun 5, 2012·European Journal of Pharmacology·Sylvia FittingKurt F Hauser
Dec 29, 2009·Neuropsychologia·Yelena BogdanovaAlice Cronin-Golomb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2021 Meta ULC. All rights reserved